search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Therapeutics


References 1 Corrigan-Curay, J et al. T-Cell Immunotherapy: Looking Forward: T Cell Immunotherapy: Optimizing Trial Design Bethesda, Maryland 10-11 September 2013. Mol. Ther., vol. 22, no. 9, pp. 1564-1574, Sep. 2014. 2 Grupp, SA et al. Chimeric Antigen Receptor – Modified T Cells for Acute Lymphoid Leukemia. N. Engl. J. Med., vol. 368, no. 16, pp. 1509–1518, Mar. 2013. 3 Saar, G and JCH. Going viral: chimeric antigen receptor T cell therapy for hematological malignancies. Immunol. Rev., vol. 263, no. 1, pp. 68-89, Dec. 2014.


can help to maximise lab space and ensure that dif- ferent cell types can be cultured simultaneously. As a result, these innovative technologies are helping researchers achieve high-quality results, while opti- mising speed and efficiency.


Conclusion Cell therapies have the potential to improve healthcare for millions of patients worldwide. However, to fully realise this goal, they require robust cell culture methods that afford high sam- ple purity and cell viability. Alongside ongoing advances in the capabilities offered by cell thera- pies, the equipment used for cell culture has also evolved. These innovative technologies are helping to maximise the consistency of results by main- taining optimal conditions and minimising the risk of cell contamination.


DDW


Mary Kay Bates is a Senior Global Cell Culture Specialist with Thermo Fisher Scientific. Her knowledge is based on 20 years of experience in academic and industrial cell and molecular biology labs, focusing on cancer and gene therapy. Mary Kay holds an MS in microbiology from the University of Wisconsin-Madison.


Advanced Cell Diagnostics Agilent Technologies, Inc Biostrata Ltd


BioTek Instruments, Inc BMG Labtech GmbH


15,17 23,33 39 25 8


ADVERTISEMENT INDEX 40-41,54


Charles River Laboratories, Inc ELRIG


IntelliCyt Corporation Labcyte, Inc


PerkinElmer, Inc


36 3 6


OBC


Quanterix Corporation Select Biosciences Ltd Source Bioscience


Taconic Biosciences, Inc Thermo Fisher Scientific


IFC IBC 4


45 60


78


Drug Discovery World Summer 2018


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80